The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Hantz Financial Services Inc.

Hantz Financial Services Inc. lowered its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 101,444 shares of the medical device company’s stock after selling 1,847 shares during the quarter. Hantz Financial Services Inc.’s holdings in Cooper Companies were worth $9,326,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ashton Thomas Securities LLC acquired a new stake in Cooper Companies during the third quarter valued at approximately $25,000. Covestor Ltd raised its stake in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after buying an additional 200 shares in the last quarter. Brown Brothers Harriman & Co. raised its stake in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after buying an additional 275 shares in the last quarter. West Financial Advisors LLC acquired a new stake in Cooper Companies during the fourth quarter valued at approximately $49,000. Finally, Friedenthal Financial acquired a new stake in Cooper Companies during the third quarter valued at approximately $50,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Citigroup cut their price objective on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Wells Fargo & Company upped their target price on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, Morgan Stanley lowered their target price on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Four analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Stock Down 0.5 %

COO opened at $98.00 on Thursday. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The stock has a market cap of $19.56 billion, a P/E ratio of 50.26, a P/E/G ratio of 2.41 and a beta of 0.99. The stock’s 50 day moving average price is $95.91 and its 200 day moving average price is $99.54. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same period last year, the firm earned $0.87 EPS. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.